TranXenoGen, Inc is a publicly traded biotechnology company listed on the Alternative Investment Market of the London Stock Exchange (TXN.L). The Company is focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products. Its product pipeline includes Anti-Neoplastic Urinary Protein ("ANUP") for the treatment of several types of cancer, Insulin and Human Serum Albumin ("HSA"). The Company believes that its technology platform willhave multiple applications including the generation of transgenic chickensfor the manufacture of high volume therapeutic proteins, animal models forthe study of disease, and high throughput production of antibodies fromgenomic derived targets for product identification. TranXenoGen isdeveloping itstechnologyplatform for the production of generic biologicals(e.g., Insulin and HSA), contract manufacturing of third party products andpotential applications in the areas of biodefense and vaccine development.In addition, the Company is exploring licensing of both the technology andproducts for certain geographic areas and commercial applications.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Nippon Suisan produces and distributes seafood products. It offers fresh and frozen fish and other fish products including fish oil. It is a subsidiary of Nippon Suisan Kaisha Ltd. The company is headquartered in Tokyo, Japan.

PrimeGen Biotech is located in Santa Ana, California and operates a 10,000 sq2. ft facility. The newly renovated facility consists of modern laboratories capable of cell processing, cell culture, molecular biology, flow cytometry, and histology. The laboratories are developed to specifically meet the requirements of our unique research approaches. The PrimeGen team includes research scientists and specialists with many years of experience in basic research of adult stem cells. As PrimeGen Biotech grows, it will remain dedicated to discovering the best possible applications for stem cell therapies and to translate the findings to therapeutic applications.

Beijing Century Jinde Biotechnology Co., Ltd., established on 2014-11-05, Business scope includes general items:R&D and application of cell technology;Environmental Protection Monitoring;Crop pest control services;Urban Greening Management;Professional cleaning,to clean,Disinfection service;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Cosmetics Wholesale;food sales(Only sell prepackaged food);Health Consulting Services(Does not include medical services);Disinfectant sales(Free of Hazardous Chemicals);Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Bioneer is a biotech company that develops molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation. From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer was established in 1992 and is based in Daejeon, South Korea.

B.G. Negev Technologies Ltd. serves as the link between industry and academic research programs. It products and technology transfer to existing companies. The company was founded in 1978 and is headquartered in Beer Sheva, Israel.

The Nanjing General Hospital of People's Liberation Army (NGH; Chinese: 中国人民解放军南京总医院), formerly Nanjing General Hospital of Nanjing Military Command (Chinese: 中国人民解放军南京军区南京总医院), or Nanjing General Hospital, The Military General Hospital, is also known as Jinling Hospital (formally Jinling Hospital of the Medical School of Nanjing University) which used to be Central Hospital. NGH is located at 305 Zhongshan East Road, Nanjing, Jiangsu Province, China. It is a large comprehensive teaching hospital integrating medical services with teaching and research.

Bioneer is a Danish advanced technology company, providing custom development- and analytical services to projects in drug development- and diagnostic companies, academic groups and hospitals. Bioneer is highly specialized within applications of cells, using their extensive knowledge anywhere from disease modeling using pluripotent stem cells and human primary cells; to recombinant protein production and biomarker identification/validation (RNA, DNA, protein) in single-cell- and tissue preparations. Furthermore, Bioneer also offers drug development of small molecules and biologics, from characterization through to a final formulation.

G��nes Diffusion SAS provides services in genetics and animal reproduction. The firm specializes in various fields related to reproduction, including bovine, porcine, equine, and rabbit artificial insemination; assistance in reproduction; bovine genetic selection programs development; and the development of a range of equipment for the swine artificial insemination. The company was founded in 1948 and is headquartered in Douai, France.

Nanmo Bio is a life sciences firm with a focus on genetically modified model organisms, mainly for life science gene function and drugs R&D.

Inner Mongolia Hongtai Medical Technology Co., Ltd., established on 2009-11-19, Business scope includes medical technology research and development

Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells. The company was founded in July 2000 as Avicore Biotechnology Research Center and merged with Medipig Korea and Optipharm Solution Center in December 2007, after which it was renamed Optipharm Solution. It entered the veterinary medicine field in April 2008 by acquiring Farmscare, and it was listed on the KOSDAQ in October 2018 after the company's name was changed to its current name Optipharm in September 2012. It is currently involved in the business of animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, and so on, and it is expanding into the field of human medicine based on the technology that it has accumulated in the field of animal medicine.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hubei Yinfeng Dingcheng Biological Engineering Co., Ltd., established on 2013-05-30, Business scope includes licensed projects:Class III Medical Device Leasing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Human stem cell technology development and application;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Remote Health Management Services;Health Consulting Services(Does not include medical services);Cosmetics Wholesale;Cosmetics Retail;Sales of daily chemical products;Healthy food(prepackaged)Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Meiya Yizhen (Beijing) Biotechnology Group Co., Ltd., established on 2015-11-03, The scope of business includes the sale of food;stem cell,Immune cells and biomedical technology development,Technical Services,technical consulting,technology transfer;sell cosmetics.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)